Neurological Iomarkers Market Trends, Business Overview, Industry Growth and Forecast to 2022-2028

The Neurological Iomarkers Market size is expected to grow at an annual average of CAGR 9% during the forecast period (2022-2028). Neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, are characterized by progressive loss of cognitive function, dementia, and movement disorders. Currently, as the incidence of Alzheimer’s disease and Parkinson’s disease is rapidly increasing worldwide, biomarker-oriented research activities in the field of neurodegenerative diseases are very important.

The following segmentation are covered in this report:

By Imaging Techniques

• Proteomics based biomarkers
• Genomic based biomarkers
• Imaging based biomarkers
• Metabolic based biomarkers

By Type

• Transcranial magnetic stimulation (TMS)
• Diffusion tensor imaging (DTI)
• Conventional structural MRI (sMRI)
• Functional magnetic resonance imaging (fMRI)
• Positron emission tomography (PET)

Company Profile

• Abbott Laboratories
• Thermo Fisher Scientific, Inc.
• Bio-Rad Laboratories, Inc.
• Merck & Co., Inc.
• Johnson & Johnson Services, Inc.
• Banyan Biomarkers, Inc.
• Myriad Genetics, Inc.
• DiaGenic ASA
• Quanterix

Scope of the report

The research study analyses the Neurological Iomarkers Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

• Market overview and growth analysis
• Import and export overview
• Volume analysis
• Current market trends and future outlook
• Market opportunistic and attractive investment segment

Geographic coverage

• North America market size and/or volume
• Latin America market size and/or volume
• Europe market size and/or volume
• Asia-pacific market size and/or volume
• Rest of the world market size and/or volume

Key Questions Answered by Neurological Iomarkers Market Report

• What was the Neurological Iomarkers Market size in 2022 and 2028; what are the estimated growth trends and market forecast (2022-2028)
• What will be the Neurological Iomarkers Market CAGR of Market during the forecast period (2022-2028)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
• Which manufacturer/vendor/players in the Neurological Iomarkers Market was the market leader in 2022?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.